SS
SULIMAN SHEHNAAZ disclosed sale in Ultragenyx Pharmaceutical Inc
SULIMAN SHEHNAAZ disclosed a sale transaction in Ultragenyx Pharmaceutical Inc (RARE) on 2026-05-18.
Action
Sale
Capital
$144,189 reported value
Insider Form 4 Activity1 evidence source
Why it matters
This signal is anchored to the Form 4 disclosure date from Dataroma insider data.